Boothbay Fund Management’s Inspire Medical Systems INSP Stock Holding History

Boothbay Fund Management’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$203K	Sell	4,559 -17,476	-79%	-$829K	﹤0.01%	1930
2026 Q1	$1.14M	Buy	22,035 +19,619	+812%	+$1.37M	0.01%	883
2025 Q4	$223K	Buy	+2,416	New	+$231K	﹤0.01%	1617
2024 Q4	–	Sell	-1,177	Closed	-$248K	–	1704
2024 Q3	$248K	Buy	+1,177	New	+$204K	0.01%	1328
2024 Q2	–	Sell	-3,789	Closed	-$717K	–	1690
2024 Q1	$814K	Buy	3,789 +1,082	+40%	+$212K	0.02%	818
2023 Q4	$551K	Buy	2,707 +1,338	+98%	+$217K	0.01%	955
2023 Q3	$272K	Buy	+1,369	New	+$345K	0.01%	1292
2023 Q2	–	Sell	-1,327	Closed	-$311K	–	2025
2023 Q1	$311K	Buy	+1,327	New	+$335K	0.01%	1491

Other funds holding INSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Boothbay Fund Management's INSP Position: Q2 2026 in Review

Boothbay Fund Management reduced its Inspire Medical Systems (INSP) stake by 79% in Q2 2026, selling an estimated $829K and leaving 4,559 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #1930.

Boothbay Fund Management first reported a position in INSP in Q1 2023 and has held it in 8 quarters since. The position peaked at $1.14M in Q1 2026. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

Boothbay Fund Management held 4,559 shares of Inspire Medical Systems worth $203K as of Q2 2026.
Boothbay Fund Management sold 17,476 Inspire Medical Systems shares in Q2 2026, an estimated $829K.
Inspire Medical Systems made up ﹤0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1930 holding.
Boothbay Fund Management first reported a position in Inspire Medical Systems in Q1 2023 and has held it in 8 quarters since.
Boothbay Fund Management's Inspire Medical Systems position peaked at $1.14M in Q1 2026.
275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.